Hey Slogger,
understand your frustration and progress not really a surprise when considering the October update:
"Work on design and process engineering has commenced along with site preparations following the successful move of the battery manufacturing plant from North Carolina to New York. Equipment manufacturers, engineers and the Imperium3 (iM3) New York team have been closely working together to meet the production time frames. Local government and environmental approvals are underway with all approvals expected in Q2 2019."
As from above, government and environmental approvals are significant when establishing a manufacturing facility. No point putting it all together only to find the request is rejected or adjustments need to be made. These are expected next quarter, but you know what governments can be like...
At this point, the planning and engineering of the facility is of utmost importance. Positively, all the machinery is available and accounted for meaning once the approvals are in place they can essentially move the equipment over and install it.
If you want to look into the cash flow statement you may also see that the forecast expenditure for this quarter includes $400,000 directly in relation to IM3NY investment. This in itself should be a positive sign and is the first time expenditure has been included for this project on a forecasted quarterly cash flow statement.
The other hindrance is obviously finance for all projects. Nothing can really be done apart from hard work behind the scenes. As stated before, I have confidence in the experience of Marc Vogts and was stoked to his appointment as Managing Director late last year and seeing his name and signature at the bottom of most recent announcements.
- Forums
- ASX - By Stock
- Ann: Quarterly Activities Report
Hey Slogger,understand your frustration and progress not really...
-
- There are more pages in this discussion • 46 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MNS (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $50.37M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
MNS (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online